Cargando…
PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis
OBJECTIVE: Pulmonary hypertension (PH) in context with interstitial lung disease (ILD) portends serious clinical consequences and a high rate of mortality. Recently published randomized controlled trials (RCTs) which assessed the pulmonary arterial hypertension (PAH)-specific drugs for pulmonary hyp...
Autores principales: | Zhao, Ning, Chen, Jun, Zhang, Mingming, Zhou, Lihui, Liu, Lisong, Yuan, Jie, Pang, Xingxue, Hu, Dayi, Ren, Xiaoxia, Jin, Zhongyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713234/ https://www.ncbi.nlm.nih.gov/pubmed/36465444 http://dx.doi.org/10.3389/fcvm.2022.992879 |
Ejemplares similares
-
Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
por: Chin, Matthew, et al.
Publicado: (2018) -
Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol
por: Chia, Karen S W, et al.
Publicado: (2017) -
Prevalence of Sarcoidosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis
por: Zhang, Shijie, et al.
Publicado: (2022) -
Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022) -
The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)